Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for prevention of renal failure in CABG surgery
IRCT20200823048491N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetylcysteine in acute kidney failure (AKF) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Kidney failure status and Creatinine increase prevention. Started Feb 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT20200823048491N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200823048491N1.